Startups tackle improving clinical trial diversity; with CAR-T, lupus patients go into remission

These three startups are trying to improve diversity in clinical trials. But experts say solving the issue may take more than just tech. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      These 3 startups are trying to improve diversity in clinical trials, a challenge experts say will take more than just tech By Ambar Castillo Adobe These 3 startups are trying to improve diversity in clinical trials. But experts say solving the issue may take more than just tech. Read More Borrowing CAR-T tool from cancer therapy, lupus patients go into remission By Isabella Cueto SAUL LOEB/AFP/Getty Images The results, in a trial of six people with severe lupus, could usher in a new era for a suite of hard-to-treat autoimmune conditions.  Read More STAT+: Lawmaker requests investigation into HCA over billing practices By Rachel Cohrs J. Scott Applewhit/AP A Democratic lawmaker is calling for an investigation into the largest for-profit hospital chain in the country, HCA Healthcare. Read More Sponsor content by The University of Texas MD Anderson Cancer Center Cancer research breakthroughs emerge from ESMO Advancing neoadjuvant immunotherapy, targeting VEGFR in colorectal cancer and a novel cell therapy for solid tumors – these represent just a few of the breakthroughs presented by MD Anderson researchers at this year's ESMO Congress. Driven by a shared mission to end cancer, the institution's physicians and scientists work seamlessly across disciplines to accelerate findings from the lab to the clinic and back. This cycle of innovation and translation enables rapid impact for patients in need. Learn more at MDAnderson.org/ESMO. 'How do we support each other?': A physician and ethicist on the difficult decisions doctors now face in abortion care By Theresa Gaffney Eric Gay/AP Matthew Wynia, a physician and medical ethicist, spoke with STAT about "professional civil disobedience" in providing abortion care. Read More Medicare provides insufficient access to opioid addiction treatment, report finds By Andrew Joseph Elise Amendola/AP Only 18% of enrollees with the diagnosis received medication to handle addiction, the health department's inspector general concluded. Read More STAT+: Swiss authorities raid Novartis offices seeking info on patents used to block rivals By Ed Silverman Ruby Wallau for STAT The Swiss Competition Commission has begun an investigation into Novartis over the possible unlawful use of a patent to block competitors. Read More Listen: Pharma's telehealth gold mine, the return of the biotech IPO, & a merger deferred By Damian Garde and Allison DeAngelis and Adam Feuerstein Our colleague Katie Palmer joins us to explain a burgeoning trend in pharmaceutical advertising that has health policy experts alarmed. Read More Opinion: Congress needs to preserve seniors' access to pharmacist care By Ilisa BG Bernstein and Paul W. Abramowitz Adobe Pharmacists can provide testing and treatment of Covid-19, flu, strep and other infectious diseases. Medicare needs to cover these services. Read More STAT+: Brazil dismisses antitrust complaint against Gilead over pricing for a hepatitis C drug By Ed Silverman Yichuan Cao/Sipa USA In a victory for Gilead, Brazilian antitrust authorities dismissed a complaint about the company's prices for a hepatitis C drug. Read More Thursday, September 15, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser